Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/LENALIDOMIDA OLAINFARM 2,5 MG CAPSULAS DURAS EFG

Approved

STANDARD

LENALIDOMIDA OLAINFARM 2,5 MG CAPSULAS DURAS EFG

Olainfarm As🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 26, 2021
Approval ID: aa3ef57fe385ab3a
Company: Olainfarm As
Type: Standard

Approval Details

Approval Id: aa3ef57fe385ab3a
Drug Cima Aemps Name: LENALIDOMIDA OLAINFARM 2,5 MG CAPSULAS DURAS EFG
Register Number: 86354
Holder Company Name: Olainfarm As
Marketing Company Name: Olainfarm As
Holder Company Detail Path: /organization/olainfarm-predstavitelstvo
Marketing Company Detail Path: /organization/olainfarm-predstavitelstvo
Authorization Date: 2021-10-26
Dosage Form: CÁPSULA DURA
Dose: 2,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Olainfarm As
Company Detail Path: /organization/olainfarm-predstavitelstvo

Company Information

Pharmaceutical Company Name: OLAINFARM, PREDSTAVITELSTVO
Country Name: Russia
City Name: moscow,moscow,country_ru
Address: d. 5 of. 1, shosse Golovinskoe

Active Ingredients

LENALIDOMIDA

2,5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 26, 2021

Approval ID

aa3ef57fe385ab3a

Type

Standard

Back to CIMA-AEMPS Approvals

LENALIDOMIDA OLAINFARM 2,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details